Elevance Health (ELV) Cost of Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Cost of Revenue data on file, last reported at $5.5 billion in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 85.04% year-over-year to $5.5 billion in Q2 2026; TTM through Jun 2026 was $117.3 billion, a 526.05% increase from a year earlier, with the FY2025 full-year figure at $148.2 billion, up 650.5% from the prior year.
• Cost of Revenue for Q2 2026 stood at $5.5 billion, down from $35.6 billion in the prior quarter.
• Over the last five years, Cost of Revenue for ELV reached as high as $111.9 billion in Q4 2023 and fell as low as -$74.3 billion in Q4 2024.
• Historically, Cost of Revenue has averaged $20.4 billion across 5 years, with a median of $28.5 billion in 2022.
• Across the five-year window, Cost of Revenue surged 2968.4% in 2023 and tumbled 166.43% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $3.6 billion in 2022, then jumped by 2968.4% to $111.9 billion in 2023, then tumbled by 166.43% to -$74.3 billion in 2024, then surged by 151.22% to $38.1 billion in 2025, then sank by 85.57% to $5.5 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $5.5 billion in Q2 2026, $35.6 billion in Q1 2026, and $38.1 billion in Q4 2025.